Your browser doesn't support javascript.
loading
BRCA2 and RAD51 promote double-strand break formation and cell death in response to gemcitabine.
Jones, Rebecca M; Kotsantis, Panagiotis; Stewart, Grant S; Groth, Petra; Petermann, Eva.
Afiliação
  • Jones RM; School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
  • Kotsantis P; School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
  • Stewart GS; School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
  • Groth P; Science for Life Laboratory, Karolinska Institutet Science Park, Solna, Sweden.
  • Petermann E; School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom. e.petermann@bham.ac.uk.
Mol Cancer Ther ; 13(10): 2412-21, 2014 Oct.
Article em En | MEDLINE | ID: mdl-25053826

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína BRCA2 / Desoxicitidina / Rad51 Recombinase / Quebras de DNA de Cadeia Dupla / Neoplasias / Antimetabólitos Antineoplásicos Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína BRCA2 / Desoxicitidina / Rad51 Recombinase / Quebras de DNA de Cadeia Dupla / Neoplasias / Antimetabólitos Antineoplásicos Idioma: En Ano de publicação: 2014 Tipo de documento: Article